Biomedicines Events Announce Your Event Here
20–22 September 2017 The 8th World ADC San Diego
San Diego, CA, USA
Now in it’s 8th year, World ADC San Diego is the industry’s definitive ADC conference. It’s mission – to be the environment in which scientists can communicate problems and solutions; share novel data and forge networks to develop more clinically impactful ADCs.
Over 3 full days, this multi-tracked conference will address every element of ADC research from early discovery to marketization making it the most comprehensive antibody drug conjugate forum you’ll attend this year.
Join your peers and 81 industry expert speakers at this year’s conference.
21–22 September 2017 Global Precision Medicine & Biomarkers Leaders Summit
More intimate roundtable discussions will also provide an opportunity for you and your peers to cover, in detail, issues such as fulfilling the potential of big data, conducting precision medicine clinical trials and advancing liquid biopsies to the clinic.
22–23 September 2017 Aptamers in Bordeaux
25 September 2017 The Road from Nanomedicine to Precision Medicine - 15th Annual International Conference
Join us for this free international conference that explores recent advances in medicine, biotech and pharma. There will be free lunch provided as well as a raffle contest.
There is no registration required to attend.
13–14 November 2017 Superbugs & Superdrugs USA
Iselin, New Jersey, USA
Building on almost two decades worth of expertise in fighting the growing threat of antimicrobial resistance (AMR), SMi Group are thrilled to announce the return of Superbugs and Superdrugs USA which arrives to Iselin, New Jersey on November 13th & 14th 2017.
Antimicrobial resistance has sparked an urgency in the development of new drugs as the industry strives for novel solutions to fight infectious diseases. Innovation and collaboration is requested at every level making Superbugs & Superdrugs USA, the perfect platform to strengthen knowledge in key principles such as funding incentives and global strategy, whilst honing in on clinical developments in areas such as immunotherapy, toxoid based vaccines and anti-body drug conjugates.
As methods move away from traditional small molecule antibiotics, this is critical time for AMR experts, government bodies and industry leaders, to come together and share ideas on the latest developments in treatment and prevention. Featured speakers include: Janssen, UNT Health Science Center, John Rex from CARB-X, BARDA, Pfizer, Merck, DemovaMed, Visterrra, Microbiotix more.
15–18 March 2018 AAT-AD/PDTM 2018
Alzheimer’s, Parkinson’s and other related neurological disorders. AAT-AD/PDTM 2018 will further advance innovative strategies in order to focus on driving successful collaborations among academia and industry.
19–20 March 2018 Superbugs & Superdrugs 2018
London, United Kingdom
SMi Group is thrilled to announce the 20th Annual Superbugs & Superdrugs Conference in London on 19th – 20th March 2018. As the global threat of antimicrobial resistance continues to develop, it is clear that a global commitment is required in order to tackle the ever-increasing problem of multidrug-resistant bacteria.
This year’s event will gather leaders from pharmaceutical companies, academia and the wider scientific community together with regulatory agencies and public-private partnerships, to discuss the growing threat of antibiotic resistance.
Join us to learn about various strategies in place to support antimicrobial resistance research & development, evaluate the latest scientific advancements for tackling antimicrobial resistance and consider potential novel candidates and alternatives to anti-microbials.
The event will also focus on the strategies pharmaceutical companies use to assist the development of new therapeutics & drugs, how to obtain funding for new projects and address why there is a current lack of incentives for researchers working in antimicrobial resistance research and development.
16–17 April 2018 5th Annual Biosimilars & Biobetters Congress
Oxford Global Conferences are proud to present the 5th Annual Biosimilars & Biobetters Congress co-located with the 11th Annual Proteins & Antibodies Congress and the 5th Annual Peptides Congress, taking place on the 16-17 April 2018 in London.
Over 450 proteins, peptides and biosimilars delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions
Over 20 presentations and case studies focusing on the key areas of the biosimilars industry including market access strategies, clinical development, commercialisation, manufacturing and bio-analytics
Two-day interactive conference addressing the following topics:
Market Access Strategies, Opportunities, Clinical Development and Commercial Challenges
Developing Biosimilars and Biobetters – Manufacturing and Bio-analytics
Free Pre-Congress Live Webinars
Biosimilars: Everyday Practice, Manufacturing Pre-Clinical Trials
Hosted by Katalin Egyed, International Oncology and Onco-biotechnology Business Unit Manager, EGIS Pharmaceuticals and Rafał Derlacz, Senior Project Manager, Polpharma.
Wednesday 7th February 2018 | 10am GMT
Register today for free: http://bit.ly/2xNJGbG
Biosimilars: The Cancer Patient Perspective
Hosted by Lydia Makaroff, Director, European Cancer Patient Coalition
Tuesday 13th February 2018 | 10am GMT
Register today for free: http://bit.ly/2j1vAAf
Can’t make the dates? Still register and a copy of the webinar recording will be sent to you.
For further information, prices & discounts please contact email@example.com
View Agenda here:
17–19 June 2018 20th Symposium on Infections in the Immunocompromised Host
We encourage all who are interested in the clinical practice and research on infections in immunocompromised host to attend the 20th ICHS Symposium in Athens, Greece June 17-19, 2018. Many symposia, plenary sessions, poster sessions will provide the attendee with opportunities to meet with outstanding leaders and clinical experts in the broad field of infectious diseases and immune-deficiencies while covering such diverse topics as new diagnostics, infections in transplant recipients, invasive fungal infections and resistance, treatment of multi-resistant bacteria, infectious complications in immunocompromised children, life-threatening infections and intensive care in neutropenic cancer patients ,antiviral and antifungal immune responses in compromised hosts, prophylaxis and treatment of viral infections in immunocompromised hosts, and others.
28–29 June 2018 RNA Therapeutics: From Base Pairs to Bedsides
UMass Medical School, Worcester, MA, USA
8–10 October 2018 4th European NF-kB subunit meeting
Grasse, French Riviera
The subject areas covered at the workshops are diverse. These include fundamental mechanistic studies of the NF-kB proteins function as transcription factors, including proteomic analysis of subunit post-translational modifications and genome wide analysis of genetic targets through ChIP Seq and RNA Seq analysis. Another focus of the workshops is the physiological and pathological roles of the NF-kB subunits. Data presented includes those using mice and other model systems, together with analysis of normal and diseased human tissues. We have sessions devoted to the role of NF-kB in the immune and inflammatory responses as well as its role in cancer.
The meeting will be held in Grasse, considered the world’s capital of perfume and was made town of art and history. The venue “Village Vacances les Cèdres” is located at 800m from Grasse downtown in the heart of a tree and flower park of 2,5 ha, a favorable framework for scientific exchange and sharing. The venue is near the international airport of Nice (south east of France), and a shuttle service will be organized to drive you to the workshop.
This is a very special occasion for us to meet and discuss and we hope that many of you will attend the conference and share this great scientific time gathering the European NF-kB community.
We look forward to seeing you in France!
4–6 November 2018 2018 NCRI Cancer Conference
Scottish Event Campus, Glasgow, UK
11–13 November 2013 9th Annual European Antibody Congress 2013
The 3 tracks cover strategies and opportunities from mAb research, mAb production, ADCs and Biosimilars.
Delegates can experience and attend only those sessions most relevant to them.
Meet the full value chain of industry executives, middle managers, public health professionals, key influencers and end-users
- Stem cells in cancer
- Stem cells, cancer & metastasis
- Stem cell aging & metabolism
- Non-coding RNAs in stem cells
- Epigenetics and cancer genomics
14–18 July 2015 ICMI 2015 - 17th International Congress of Mucosal Immunology
- Biology of innate and adaptive immune responses at mucosal surfaces
- The host-microbiota interface
- Impact of the microbiota on systemic immunity
- Mucosal immunity in humans
- Translational immunology in inflammatory bowel disease
- Mechanisms of antigen uptake
- Regulation of immunity in the intestine, lung and UG tract
3–4 September 2015 Cancer diagnosis and Therapy Congress
19–22 October 2015 Stem Cells: From Basic Biology to Disease Therapies
The International Society for Stem Cell Research (ISSCR) together with the Cold Spring Harbor Asia (CSHA) present Stem Cells: From Basic Biology to Disease Therapies International Symposium. The International Symposia series expands the global reach of ISSCR and CSHA educational programming and invites attendees from around the world.
Stem Cells: From Basic Biology to Disease Therapies will highlight the latest directions of stem cell research, including new techniques in genome editing, that are moving the field to new understandings of disease and toward therapeutic applications. Hear from leaders in pluripotent stem cell biology, stem cells of the mesoderm and endoderm lineages, and in driving stem-cell based products into clinical trials.
The main objective of the Symposium is to bring together worldwide experts from academia, industry, doctors, policy makers and patient organisations in the field of Big data in Health Care to exchange about state-of-the-art research and technologies. The aim is to critically review the current scientific knowledge and the entire life cycle of Big Data in Health Care.
The conference will take place from 28 to 29 October 2015 in the Hôtel Légère, Luxembourg-Munsbach.
Boston, MA, USA
Boston, MA, USA
San Diego, CA, USA
12–13 July 2016 Extracellular Vesicles 2016
1–2 November 2016 Cancer Immunotherapy & Biofluid Biopsies 2016